Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2024-06-28 00:00:00 ET · period of report 2024-06-26 · accession 0001415889-24-018441 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-28 | 2024-06-26 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +2,500 | 2,500 | New | $0 |
| D | 2024-06-28 | 2024-06-26 | JANX | Kung Winston | Dir | A - Grant | $0.00 | +8,350 | 8,350 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-26 | A | A | 2,500 | $0.00 | 2,500 | D | — | — | (F1) Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of (i) June 26, 2025 and (ii) the date of the next annual meeting of the Issuer's stockholders, in each case, subject to the Reporting Person's continuous service on such date. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-26 | A | A | 8,350 | $0.00 | 8,350 | D | $39.80 · — to 2034-06-25 | 8,350 Common Stock | (F2) The shares subject to the option will vest in equal monthly installments over the 12 months following June 26, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service on each such date. |